The first of these is the unavailability of standards and guidelines from a professional and/or scientific society for tissue FISH testing, or more specifically for ALK FISH testing in NSCLC, and the approval of this assay by the FDA. The gene discussed is ALK; the disease is non-small cell lung carcinoma.